A recent and more extensive ( N = 10,690 people with diabetes followed up over 67 years) historical cohort study observed a reduced association between GLP-1RA use compared with non-use for depressive and, more pronouncedly, anxiety disorders incidence, especially in women 32
Knows Your Cycle GLPIQ tracks where you are in your injection cycle and adjusts everything around it: lighter meals on nausea days, higher protein when appetite returns, and smarter targets as your medication level shifts
Heres what the evidence currently suggests: Animal studies report mixed findings, some suggesting potential bone-protective effects, though human data is more limited
Patients can also use the contact page to request next steps
This can help identify patterns and determine if a particular injection site is more likely to cause problems